Reviewing AppYea (OTCMKTS:APYP) & TruBridge (NASDAQ:TBRG)

TruBridge (NASDAQ:TBRG) and AppYea (OTCMKTS:APYP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Institutional and Insider Ownership

88.6% of TruBridge shares are owned by institutional investors. 3.6% of TruBridge shares are owned by insiders. Comparatively, 0.5% of AppYea shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for TruBridge and AppYea, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	0	2	2	0	2.50
AppYea	0	0	0	0	0.00

TruBridge presently has a consensus target price of $14.50, suggesting a potential downside of 29.82%. Given TruBridge’s stronger consensus rating and higher possible upside, equities research analysts plainly believe TruBridge is more favorable than AppYea.

Profitability

This table compares TruBridge and AppYea’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TruBridge	-17.72%	1.78%	0.78%
AppYea	N/A	N/A	-269.35%

Valuation and Earnings

This table compares TruBridge and AppYea”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$337.67 million	0.91	-$44.76 million	($4.09)	-5.05
AppYea	N/A	N/A	-$1.82 million	N/A	N/A

AppYea has lower revenue, but higher earnings than TruBridge.

Volatility and Risk

TruBridge has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, AppYea has a beta of 2.02, suggesting that its share price is 102% more volatile than the S&P 500.

Summary

TruBridge beats AppYea on 8 of the 11 factors compared between the two stocks.

About TruBridge

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

About AppYea

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The company was founded in 2012 and is based in Gan Yavne, Israel.